Return to Article Details
Change in serum lipid profiles and glucose subsequent to changing from stavudine/lamivudine to zidovudine/lamivudine in non-nucleoside reverse transcriptase inhibitors based hostile to retroviral regimens in Southern Ethiopia
Download
Download PDF